Mark C. Lanasa

4.4k citations
76 papers · 2.3k · h-index 28

Impact in

  • Genetics top 1%
    • Chronic Lymphocytic Leukemia Research
    • Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
  • Immunology top 5%
    • Immunodeficiency and Autoimmune Disorders
    • Immune Cell Function and Interaction

Papers in

    • Chronic Lymphocytic Leukemia Research 48
    • Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities 6
    • Immunodeficiency and Autoimmune Disorders 19

Mark C. Lanasa

74 papers receiving 2.3k citations

Peers

Mark C. Lanasa
Comparison fields: 5 of 86
  • Genetics 798
  • Immunology 812
  • Pathology and Forensic Medicine 536
  • Oncology 771
  • Hematology 169
Replace Adèle Telenius with:
Adèle Telenius Canada
S Dirnhofer Switzerland
Todd W. Kelley United States
András Matolcsy Hungary
Thorsten Raff Germany
Michelle Francesco United States
Olivier Caron France
Mathias Witzens‐Harig Germany
C.A. Griffin United States
EJ Dreef Netherlands
Mark C. Lanasa relative to Adèle Telenius Canada Adèle Telenius's profile →
Citations per field
00.5×10×13×
Adèle Telenius · 1×
Citations per year

Countries citing papers authored by Mark C. Lanasa

Since Specialization
Citations

This map shows the geographic impact of Mark C. Lanasa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark C. Lanasa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark C. Lanasa more than expected).

Fields of papers citing papers by Mark C. Lanasa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark C. Lanasa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark C. Lanasa. The network helps show where Mark C. Lanasa may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark C. Lanasa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark C. Lanasa Line = papers co-authored together Mark C. Lanasa links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2021158
2 2010143
3 2012138
4 2018114
5 2003109
6 1997107
7 2011103
8 201981
9 201073
10 201372
11 201968
12 202067
13 199960
14 201852
15 201751
16 200149
17 200949
18 201943
19 201541
20 201938

About Mark C. Lanasa

Mark C. Lanasa is a scholar working on Genetics, Immunology, Pathology and Forensic Medicine, Oncology and Genetics, having authored 76 papers that have together received 2.3k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (48 papers), Lymphoma Diagnosis and Treatment (23 papers), Immunodeficiency and Autoimmune Disorders (19 papers), PARP inhibition in cancer therapy (8 papers), Cancer Immunotherapy and Biomarkers (7 papers), Advanced Breast Cancer Therapies (6 papers), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (6 papers) and Acute Lymphoblastic Leukemia research (6 papers). The work is most often cited by research in Genetics (798 citations), Immunology (812 citations), Pathology and Forensic Medicine (536 citations), Oncology (771 citations) and Hematology (169 citations). Mark C. Lanasa has collaborated with scholars based in United States, United Kingdom and South Korea. Frequent co-authors include W. Allen Hogge, Tait D. Shanafelt, Urvashi Surti, J. Brice Weinberg, Paolo Ghia, Andy C. Rawstron, Eric P. Hoffman, Ola Landgren, Jon P. Gockerman and Alicia D. Volkheimer. Their work appears in journals such as Blood, Journal of Clinical Oncology, Leukemia, Annals of Oncology and The American Journal of Human Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact